Related Experiment Video
Updated: Jul 2, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MMRN1 suppresses thyroid cancer progression via activation of the Hippo signaling pathway
Meihua Zhang1, Junjun Guo2, Jun Sun3
1Endoscopy Center, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, Shandong, China.
Introduction:
Thyroid cancer (TC) represents the most frequently diagnosed malignancy of the endocrine system, with its incidence continuing to increase worldwide. Multimerin 1 (MMRN1), a glycoprotein implicated in various cancers, exhibits context-dependent roles, but its function in TC remains unexplored. The Hippo pathway, a key regulator of cell proliferation and apoptosis, is frequently dysregulated in TC. We hypothesized that MMRN1 inhibits TC progression by activating the Hippo signaling pathway.
Methods:
Bioinformatics analysis of GSE33630 identified differentially expressed genes (DEGs) in TC. MMRN1 expression was validated in TC cell lines (BCPAP, TPC-1, IHH-4, HTH83) and normal thyroid cells (NTHY-ORI3.1) via RT-qPCR and Western blot. Functional assays assessed proliferation, migration, and invasion. Hippo pathway activity was evaluated after MMRN1 modulation. Oxidative stress and ferroptosis markers (ROS, SOD, CAT, GSH, MDA, GPX4, TF, TFR1) were analyzed.
Results:
MMRN1 was downregulated in TC tissues and cell lines. Overexpression of MMRN1 suppressed TC cell proliferation, migration, and invasion while promoting apoptosis. Mechanistically, MMRN1 activated Hippo signaling, increasing p-MST1/2, p-LATS1/2, and p-YAP levels. Verteporfin reversed these effects. Additionally, MMRN1 modulated oxidative stress markers (including ROS and the indirect lipid peroxidation marker MDA) and altered GPX4 activity and iron metabolism, suggesting enhanced ferroptosis sensitivity.
Conclusion:
MMRN1 acts as a tumor suppressor in TC by activating the Hippo pathway and modulating oxidative stress and ferroptosis. These findings highlight MMRN1 as a potential therapeutic target for TC treatment.
Insights
Multimerin 1 (MMRN1) suppresses thyroid cancer (TC) by activating the Hippo pathway and influencing oxidative stress and ferroptosis. This discovery presents MMRN1 as a promising therapeutic target for TC treatment.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Thyroid cancer (TC) incidence is rising globally, making it the most common endocrine malignancy.
- The role of Multimerin 1 (MMRN1) in TC is unknown, despite its involvement in other cancers.
- The Hippo pathway is crucial for regulating cell growth and is often altered in TC.
Purpose of the Study:
- To investigate the function of MMRN1 in thyroid cancer.
- To determine if MMRN1 affects the Hippo signaling pathway in TC.
- To explore MMRN1's impact on oxidative stress and ferroptosis in TC.
Main Methods:
- Bioinformatics analysis identified differentially expressed genes in TC.
- MMRN1 expression was confirmed in TC cell lines and normal cells using RT-qPCR and Western blot.
- Functional assays, Hippo pathway activity assessments, and analysis of oxidative stress/ferroptosis markers were performed.
Main Results:
- MMRN1 expression was found to be decreased in TC tissues and cell lines.
- Overexpressing MMRN1 inhibited TC cell proliferation, migration, and invasion, while promoting apoptosis.
- MMRN1 activated the Hippo pathway and modulated oxidative stress and ferroptosis markers, indicating increased sensitivity to ferroptosis.
Conclusions:
- MMRN1 functions as a tumor suppressor in thyroid cancer.
- MMRN1 exerts its effects by activating the Hippo pathway and influencing oxidative stress and ferroptosis.
- MMRN1 represents a potential therapeutic target for managing thyroid cancer.
More Related Videos
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor
Published on: September 13, 2018
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Hyperthyroidism II: Pathophysiology
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Abnormal Proliferation